ENDPOINTS

Neuron23's $96.5M Series D raise; Rivus' Phase 2 data in MASH

Plus, news about Amarin, Recordati, ArriVent, Liquidia, Healthcare Royalty, Lexeo, Perceptive, venBio, Novo Nordisk and Cidara: Neuron23 raises $96.5M as it starts Parkinson’s trial: The Bay Area biotech did not

Jun 24, 2025 - 16:00
 0
Neuron23's $96.5M Series D raise; Rivus' Phase 2 data in MASH
Plus, news about Amarin, Recordati, ArriVent, Liquidia, Healthcare Royalty, Lexeo, Perceptive, venBio, Novo Nordisk and Cidara: Neuron23 raises $96.5M as it starts Parkinson’s trial: The Bay Area biotech did not
Read More

Tags:

Previous Article

As Wind and Solar Grow, China Ships More Coal Overseas

Next Article

Google Reportedly Taking 4% Stake In Gentle Monster To Take On Ray-Ban Meta

Related Posts

Gilead notches another Phase 3 win for Trodelvy in triple-negative breast cancer

Gilead notches another Phase 3 win for Trodelvy in trip...

May 23, 2025  0

FDA reinstates generic drug policy group let go in April firings

FDA reinstates generic drug policy group let go in Apri...

Jun 9, 2025  0

Lilly pledges more than $650M to muscle health biotech; Cogent gets $50M

Lilly pledges more than $650M to muscle health biotech;...

Jun 11, 2025  0